Menopause Market Size, Share, Growth & Industry Analysis, By Product Type (Dietary Supplements, Prescribed drugs, Medical Devices, and Others), By Distribution Channel (Hospitals and Clinics, Femtech Platforms, and Online Retailers), By Type (Diagnosis, Screening, and Treatment) and Regional Analysis, 2024-2031

Menopause Market Size

The global Menopause Market size was valued at USD 16.96 billion in 2023 and is projected to grow from USD 17.77 billion in 2024 to USD 25.89 billion by 2031, exhibiting a CAGR of 5.52% during the forecast period. The growth of the market is mainly driven by demographic shifts and the increasing awareness and acceptance of menopause-related issues.

In the scope of work, the report includes solutions offered by companies such as Novartis AG, Pfizer Inc., Emcure, Teva Pharmaceutical Industries Ltd., Bayer AG, Procter & Gamble, Pharmavite, Thorne., Cipla, Glenmark Pharmaceuticals Ltd. and others.

The growth of the market is primarily fueled by several factors such as the aging population, increasing awareness and acceptance of menopause-related issues, and advancements in healthcare technology. One of the significant factors contributing to this robust growth is the demographic shift.

• For instance, according to the government of Ireland, three-quarters of women aged over 35 experience peri-menopause and menopause.

Additionally, the menopause market is influenced by trends such as the rising demand for personalized healthcare solutions, with tailored treatment plans based on genetic, lifestyle, and physiological factors becoming increasingly prevalent. Key segments within the market include hormone replacement therapy (HRT), non-hormonal medications, herbal supplements, dietary and lifestyle interventions, as well as healthcare services such as counseling and support groups.

Menopause is a natural biological process that marks the end of a woman's reproductive years. It typically occurs between the ages of 45 and 55, though individual timing may vary. During menopause, the ovaries gradually stop producing eggs, accompanied by a decline in hormone levels, particularly estrogen and progesterone.

This hormonal shift leads to various physical and emotional changes, including irregular menstrual cycles, hot flashes, night sweats, mood swings, and vaginal dryness. While menopause is a normal part of aging, it may induce discomfort and impact the quality of life for some women. Management strategies include hormone replacement therapy, lifestyle modifications, and medications to alleviate symptoms and promote overall well-being.

• Additionally, according to the Department of Health, Ireland, 17% of women in menopause experience severe symptoms, highlighting the growing demand for effective management solutions.

Analyst’s Review

The menopause market presents a lucrative opportunity for healthcare innovation, fueled by demographic shifts and rising awareness of women's health issues. Key industry players are strategically investing in research and development to introduce cutting-edge therapies, with a major focus on alternatives to traditional hormone replacement therapy and personalized medicine.

Collaborative efforts with healthcare providers, research institutions, and pharmaceutical firms are crucial for developing and commercializing innovative products. Additionally, mobile applications, wearable devices, and online platforms provide personalized health information, symptom tracking, and virtual consultations.

Companies such as HSBC India, IBM, HUL, Standard Chartered Bank, NatWest Group, and Intuit are implemeting initiatives to normalize menopause discussions, enhance medical coverage, offer mental health support, institute flexible work policies, and conduct awareness campaigns. Through innovation, collaboration, and digital transformation, industry leaders are poised to meet the evolving needs of menopausal women and stimulate market growth.

Menopause Market Growth Factors

The menopause market is experiencing significant growth, primarily attributable to the increasing prevalence of postmenopausal symptoms due to a growing shift toward sedentary lifestyles. Modern lifestyle changes, such as reduced physical activity and increased stress levels, have intensified menopausal symptoms such as hot flashes, mood swings, and sleep disturbances.

• According to the North American Menopause Society, approximately 6,000 women in the U.S. reach menopause each day, totaling around 2 million women annually.

This notable demographic shift highlights the rising demand for effective menopause management solutions, including hormone replacement therapies, dietary supplements, and lifestyle interventions. The market is expected to grow significantly as awareness of the impact of menopause on women's health and quality of life increases.

However, the lack of awareness and education regarding menopausal symptoms among both women and healthcare providers leads to mismanagement of the menopause cycle, thereby impacting market growth. To address this challenge, pharmaceutical companies are developing educational campaigns targeted toward both women and healthcare professionals. These campaigns aim to enhance awareness regarding common symptoms, treatment options, and the importance of open communication. 

Additionally, there is a growing emergence of telehealth platforms focusing on menopause, providing women with convenient access to qualified healthcare providers specializing in this area. By prioritizing education and accessibility, key players are working to narrow the knowledge gap and empower women to effectively navigate their menopause experiences.

Menopause Market Trends

Public health campaigns and educational initiatives are playing a crucial role in the menopause market by increasing awareness regarding menopause and the various treatment options available. These efforts are designed to educate women about the natural progression of menopause, its symptoms, and effective management strategies. By disseminating accurate information through media, community programs, and healthcare providers, these campaigns are helping demystify menopause and reduce the stigma often associated with it.

• For instance, Abbott is advancing ‘The Next Chapter’ campaign on menopause by introducing innovative strategies to address the silence on this topic. In December 2023, the company unveiled an engaging initiative titiled  'Real, Made up, or Mine?' in india, to promote meaningful discussions about menopause.

Additionally, healthcare providers are increasingly initiating conversations about menopause during routine checkups, empowering women to seek information and solutions. Educational initiatives are further empowering women to take proactive steps toward managing their health during menopause, thereby augmenting market expansion.

Advancements in personalized medicine are significantly impacting the menopause market. Tailored treatment plans based on genetic, lifestyle, and physiological factors are becoming increasingly prevalent, ensuring that women receive individualized care that effectively addresses their specific menopausal symptoms.

This trend involves the integration of genetic testing, biomarker analysis, and comprehensive health assessments to identify personalized treatment options that optimize efficacy and minimize side effects. Personalized medicine is revolutionizing menopausal care by offering women tailored solutions that better align with their unique needs and preferences.

Segmentation Analysis

The global market is segmented based on product type, distribution channel, and geography.

By Product Type

Based on product type, the menopause market is categorized into dietary supplements, prescribed drugs, medical devices, and others. The prescribed drugs segment garnered the highest revenue of USD 7.00 billion in 2023. The segment is witnessing significant growth due to increasing awareness regarding holistic approaches to managing menopausal symptoms and improving overall well-being.

Dietary supplements offer a convenient and accessible option for women experiencing menopausal symptoms to address specific nutritional deficiencies and support hormonal balance. These supplements may contain a variety of vitamins, minerals, herbal extracts, and botanicals, each targeting different symptoms commonly associated with menopause, such as hot flashes, mood swings, and bone health. .

Herbal supplements such as black cohosh, red clover, and evening primrose oil are gaining immense popularity due to their purported benefits in alleviating menopausal symptoms, such as hot flashes and vaginal dryness, without the side effects associated with hormone replacement therapy.

By Distribution Channel

Based on distribution channel, the market is divided into hospitals and clinics, femtech platforms, and online retailers. The hospitals and clinics segment captured the largest menopause market share of 41.08% in 2023. Hospitals and clinics serve as a vital hub for women seeking comprehensive healthcare services and support during the menopausal transition.

These facilities offer a range of diagnostic, treatment, and support services tailored to address the diverse needs of menopausal women. Healthcare professionals, such as gynecologists, endocrinologists, and primary care physicians, play a crucial role in diagnosing menopause, assessing individual risk factors, and developing personalized treatment plans to alleviate menopausal symptoms and improve overall well-being.

Moreover, hospitals and clinics function as centers for education and empowerment, providing resources, information, and counseling to help women navigate the menopausal journey effectively. These factors are expected to boost the growth of the segment in the foresseable future.

By Type

Based on type, the market is categorized into diagnosis, screening, and treatment. The treatment segment is poised to attain the highest valuation of USD 11.55 billion by 2031. This segmental growth is fostered by increasing awareness and acceptance of menopause-related health issues. Hormone replacement therapy (HRT) remains the most common and effective treatment, alleviating symptoms such as hot flashes and night sweats.

Additionally, non-hormonal therapies, including SSRIs and SNRIs, are highly favored by women seeking alternatives to HRT, with key players such as GlaxoSmithKline and Eli Lilly leading this trend. Furthermore, natural and complementary therapies, such as dietary supplements and herbal remedies, are becoming increasingly popular due to a growing preference for holistic approaches, thereby fostering segmental growth.

Menopause Market Regional Analysis

Based on region, the global market is classified into North America, Europe, Asia-Pacific, MEA, and Latin America.

North America accounted for the largest menopause market share of 35.28% in 2023, with a valuation of USD 5.98 billion. This growth is augmented by an aging population, increased awareness regarding women's health, and a strong healthcare infrastructure in the region.

The U.S. and Canada are at the forefront of this expansion, propelled by the rising demand for hormone replacement therapies, non-hormonal treatments, and dietary supplements to manage symptoms such as hot flashes and mood swings. The region's well-established healthcare system and access to specialists support personalized care plans and advanced treatments.

Innovation plays a pivotal role in the advancement of new therapies, including bioidentical hormones and non-hormonal alternatives, being developed. Additionally, there is a growing preference for holistic approaches, such as acupuncture and herbal supplements. Demographic trends, high consumer awareness, and continuous innovation position North America as a leading region in the global market.

Asia-Pacific is anticipated to witness the highest growth, registering a CAGR of 6.23% over the forecast period. The regional market growth is reinforced by notable demographic shifts, increasing healthcare awareness, and rapid economic growth. The growing aging female population is fueling the demand for healthcare services and products to manage menopausal symptoms, such as hormone replacement therapies, non-hormonal treatments, and dietary supplements.

Rising awareness and acceptance of menopause-related health issues are prompting an increasing number of women to seek medical advice and treatment, supported by improvements in healthcare infrastructure. Economic growth and higher disposable incomes enable more women to afford these healthcare products and services, fostering investment in healthcare innovation and research.

Additionally, there is a growing trend toward integrating traditional medicine practices such as Ayurveda and Traditional Chinese Medicine, with modern medical treatments to provide comprehensive healthcare solutions. The Asia Pacific menopause market is poised to observe sustained expansion, characterized by significant growth potential attributable to demographic trends, increased awareness, and economic development.

Competitive Landscape

The global menopause market report will provide valuable insight with an emphasis on the fragmented nature of the industry. Prominent players are focusing on several key business strategies such as partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their product portfolio and increase their market shares across different regions.

Companies are implementing impactful strategic initiatives, such as expanding services, investing in research and development (R&D), establishing new service delivery centers, and optimizing their service delivery processes, which are likely to create new opportunities for market growth.

List of Key Companies in Menopause Market

• Novartis AG
• Pfizer Inc.
• Emcure
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Procter & Gamble
• Pharmavite
• Thorne
• Cipla
• GLENMARK PHARMACEUTICALS LTD.

Key Industry Developments

• August 2023 (Product Launch): Clearblue, ventured into a new category, menopause. The company launched the Clearblue Menopause Stage Indicator, a groundbreaking product that combined a woman's urine FSH measurements with her age and cycle history to determine her likely menopause stage. By introducing this innovative solution, Clearblue aimed to amplify the conversation around menopause, providing women with valuable insights and empowering them to navigate this life stage with greater confidence and understanding.
• December 2023 (Acquisition): Pharmavite LLC, the manufacturer of Nature Made vitamins, expanded its range of women's health brands through the acquisition of Bonafide Health. Bonafide Health was dedictaed to offering new solutions for menopause management, thereby addressing a significant market need. The acquisition marked a strategic move by Pharmavite LLC to diversify its product portfolio and cater to the growing demand for innovative menopause products.

The global menopause market is segmented as:

By Product Type

• Dietary Supplements
• Prescribed drugs
• Medical Devices
• Others

By Distribution Channel

• Hospitals and Clinics
• Femtech Platforms
• Online Retailers

By Distribution Type

• Diagnosis
• Screening
• Treatment

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • U.K.
  • Spain
  • Germany
  • Italy
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Middle East & Africa
  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America